@article{96012,
  keywords = {Cell mediated immunity, epidermodysplasia, leprosy},
  author = {Tripathy D and Neema S and Kinra P and Sinha P},
  title = {Lepromatous leprosy in a case of epidermodysplasia verruciformis - A coincidence or a result of defective cell-mediated immunity?},
  abstract = {<p>Epidermodysplasia verruciformis (EDV) is a rare, autosomal recessive, genetic disorder of immune dysregulation characterized by increased susceptibility to cutaneous human papilloma virus infections. It was first described by Lewandowsky and Lutz in 1922 as a form of epidermal nevus. Its association with skin cancers was proposed by Sullivan and Ellis in 1939. Initial lesions often occur in childhood and are of two types; lifelong eruptions of pityriasis versicolor like lesions and flat wart like papules. The latter is characterized by malignant transformation in 35%-50% of patients especially after 40-50 years of age. Bowen disease is the most common tumor followed by invasive squamous cell carcinoma, however, metastasis is rarely encountered.</p>},
  year = {2021},
  journal = {International journal of mycobacteriology},
  volume = {10},
  pages = {210-213},
  month = {01/2021},
  issn = {2212-554X},
  url = {https://www.ijmyco.org/temp/IntJMycobacteriol102210-3371611_092156.pdf},
  doi = {10.4103/ijmy.ijmy_19_21},
  language = {eng},
}